Saleh Ezzeldin, Swamy Geeta K, Moody M Anthony, Walter Emmanuel B
1 Duke University School of Medicine, Durham, NC, USA.
Clin Pediatr (Phila). 2017 May;56(5):435-442. doi: 10.1177/0009922816675116. Epub 2016 Oct 23.
Antipyretic analgesics are commonly used to prevent and treat adverse events following immunizations. Current practice discourages routine use due to possible blunting of vaccine immune responses. We surveyed 150 parents/caregivers of recently vaccinated 6- and 15-month-old children to determine the prevalence of and beliefs regarding antipyretic analgesics use around vaccinations. 11% used them prophylactically, before vaccination. Use in the first 48 hours after vaccination was 64%, primarily to prevent and/or treat fever and pain. Acetaminophen was administered 2.6 times more frequently than ibuprofen. Ibuprofen was used more in the 15-month compared with the 6-month-old children (28% vs 7.4%, respectively, P = .001). The majority of caregivers disagreed with their use for fever (53%) or pain (59%). Antipyretic analgesic use, including prophylaxis, around vaccinations was common in our study population. Effective interventions are needed to target parents/caregivers to eliminate unnecessary antipyretic analgesic use around vaccination time and foster nonmedication alternatives.
解热镇痛药常用于预防和治疗疫苗接种后的不良事件。由于可能会削弱疫苗免疫反应,目前的做法不鼓励常规使用。我们对150名6个月和15个月大近期接种疫苗儿童的父母/照顾者进行了调查,以确定接种疫苗前后使用解热镇痛药的流行情况和相关观念。11%的人在接种疫苗前预防性使用。接种疫苗后48小时内的使用率为64%,主要用于预防和/或治疗发热和疼痛。对乙酰氨基酚的使用频率比布洛芬高2.6倍。与6个月大的儿童相比,15个月大的儿童使用布洛芬的比例更高(分别为28%和7.4%,P = .001)。大多数照顾者不同意在发热(53%)或疼痛(59%)时使用。在我们的研究人群中,接种疫苗前后使用解热镇痛药(包括预防性使用)的情况很常见。需要采取有效的干预措施,针对父母/照顾者,以消除在接种疫苗期间不必要地使用解热镇痛药,并推广非药物替代方法。